Treatment of Sarcoidosis

Disease-a-Month

Volumn 55, Issue 11, 2009, Pages 704-718

  King, Christopher S ^a   Kelly, William ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOPLEGIC AGENT; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; KETOCONAZOLE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PENTOXIFYLLINE; PLACEBO; POTASSIUM IODIDE; PREDNISONE; THALIDOMIDE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSENCE OF SIDE EFFECTS; ACNE; AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; EYE SARCOIDOSIS; EYE TOXICITY; FATIGUE; HEART SARCOIDOSIS; HUMAN; HYPERCALCEMIA; HYPERTENSION; INFECTION; KIDNEY SARCOIDOSIS; LEUKOPENIA; LIVER TOXICITY; LOW DRUG DOSE; LUNG INJURY; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MOOD CHANGE; NAUSEA; ORGAN TRANSPLANTATION; OSTEOPOROSIS; OUTCOME ASSESSMENT; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; REVIEW; SARCOIDOSIS; SIDE EFFECT; SKIN SARCOIDOSIS; STOMATITIS; TREATMENT DURATION; TREATMENT INDICATION; TUBERCULOSIS; WEIGHT GAIN;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIMALARIALS; DECISION MAKING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; ORGAN TRANSPLANTATION; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350141915     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.06.002     Document Type: Review

References (46)

1. Israel H.L., Sones M., and Harrell D. Cortisone treatment of sarcoidosis: Experience with thirty-six cases. J Am Med Assoc 156 (1954) 461-466
2. Baughman R.P., Costabel U., and du Bois R.M. Treatment of sarcoidosis. Clin Chest Med 29 (2008) 533-548
3. Paramothayan N.S., Lasserson T.J., and Jones P.W. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev (2005) CD001114
4. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the world association of sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS Board Of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999) 736-755
5. Erkkila S., Froseth B., Hellstrom P.E., et al. Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. Sarcoidosis 5 (1988) 106-110
6. Alberts C., van der Mark T.W., and Jansen H.M. Inhaled budesonide in pulmonary sarcoidosis: A double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J 8 (1995) 682-688
7. Pietinalho A., Tukiainen P., Haahtela T., et al. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 121 (2002) 24-31
8. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49 (2000) 1-51
9. American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update. Arthritis Rheum 44 (2001) 1496-1503
10. Vucinic V.M. What is the future of methotrexate in sarcoidosis?. A study and review. Curr Opin Pulm Med 8 (2002) 470-476
11. Rose A.S., Tielker M.A., and Knox K.S. Hepatic, ocular, and cutaneous sarcoidosis. Clin Chest Med 29 (2008) 509-524
12. Baughman R.P., Winget D.B., and Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 17 (2000) 60-66
13. Lower E.E., and Baughman R.P. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 155 (1995) 846-851
14. Baughman R.P., Koehler A., Bejarano P.A., et al. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 163 (2003) 615-620
15. Baughman R.P., and Lower E.E. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 54 (1999) 742-746
16. Doherty C.B., and Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs 68 (2008) 1361-1383
17. Hassid S., Choufani G., Saussez S., et al. Sarcoidosis of the paranasal sinuses treated with hydroxychloroquine. Postgrad Med J 74 (1998) 172-174
18. James D.G., Barter S., Jash D., et al. Sarcoidosis of the upper respiratory tract (SURT). J Laryngol Otol 96 (1982) 711-718
19. Barre P.E., Gascon-Barre M., Meakins J.L., et al. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 82 (1987) 1259-1262
20. Sharma O.P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 55 (1998) 1248-1254
21. Baltzan M., Mehta S., Kirkham T.H., et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 160 (1999) 192-197
22. Denys B.G., Bogaerts Y., Coenegrachts K.L., et al. Steroid-resistant sarcoidosis: Is antagonism of TNF-alpha the answer?. Clin Sci Lond 112 (2007) 281-289
23. Santos E., Shaunak S., Renowden S.A., et al. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry (2008) (Epub ahead of print)
24. Barnabe C., McMeekin J., Howarth A., et al. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol 35 (2008) 1686-1687
25. Stagaki E., Mountford W.K., Lackland D.T., et al. The treatment of lupus pernio: The results of 116 treatment courses in 54 patients. Chest 135 (2009) 468-476
26. Rosen T., and Doherty C. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion. Dermatol Online J 13 (2007) 14
27. Rossman M.D., Newman L.S., Baughman R.P., et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 (2006) 201-208
28. Judson M.A., Baughman R.P., Costabel U., et al. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial. Eur Respir J 31 (2008) 1189-1196
29. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha-California, 2002-2003. MMWR Morb Mortal Wkly Rep 53 (2004) 683-686
30. Shah L. Lung transplantation in sarcoidosis. Semin Respir Crit Care Med 28 (2007) 134-140
31. Gottlieb J.E., Israel H.L., Steiner R.M., et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 111 (1997) 623-631
32. Mihailovic-Vucinic V., and Jovanovic D. Pulmonary sarcoidosis. Clin Chest Med 29 (2008) 459-473
33. O'Donnell A.E. Bronchiectasis. Chest 134 (2008) 815-823
34. Diaz-Guzman E., Farver C., Parambil J., et al. Pulmonary hypertension caused by sarcoidosis. Clin Chest Med 29 (2008) 549-563
35. Ayyala U.S., Nair A.P., and Padilla M.L. Cardiac sarcoidosis. Clin Chest Med 29 (2008) 493-508
36. Aizer A., Stern E.H., Gomes J.A., et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96 (2005) 276-282
37. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
38. Yazaki Y., Isobe M., Hiroe M., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88 (2001) 1006-1010
39. Zajicek J.P., Scolding N.J., Foster O., et al. Central nervous system sarcoidosis-Diagnosis and management. QJM 92 (1999) 103-117
40. Lower E.E., and Weiss K.L. Neurosarcoidosis. Clin Chest Med 29 (2008) 475-492
41. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 84 (2000) 110-116
42. Sharma O.P. Hypercalcemia in granulomatous disorders: A clinical review. Curr Opin Pulm Med 6 (2000) 442-447
43. Berliner A.R., Haas M., and Choi M.J. Sarcoidosis: The nephrologist's perspective. Am J Kidney Dis 48 (2006) 856-870
44. Requena L., and Yus E.S. Erythema nodosum. Dermatol Clin 26 (2008) 425-438
45. Wirnsberger R.M., de Vries J., Breteler M.H., et al. Evaluation of quality of life in sarcoidosis patients. Respir Med 92 (1998) 750-756
46. Lower E.E., Harman S., and Baughman R.P. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest 133 (2008) 1189-1195